1887

Abstract

The conversion of the cellular isoform of the prion protein (PrP) to the abnormal disease-associated isoform (PrP) has been simulated in cell-free conversion reactions in which PrP-enriched preparations induce the conformational transition of PrP into protease-resistant PrP (PrP-res). We explored the utility of recombinant hamster (Ha)PrP purified from baculovirus-infected insect cells (bacHaPrP) as a replacement for mammalian-derived HaPrP in the conversion reactions. Protease-resistant recombinant HaPrP was generated after incubation of S-bacHaPrP with PrP-enriched preparations. Moreover strain-specific PrP-res was also reproduced using insect-cell derived HaPrP and PrP from two different strains of hamster-adapted transmissible mink encephalopathy, designated hyper (HY) and drowsy (DY). Two strain-mediated properties were tested: (i) molecular mass of the protease-digested products and (ii) relative resistance to proteinase K (PK) digestion. Similar to generation of PrP and PrP, the converted products selectively reproduced both characteristics, with the DY conversion product being smaller in size and less resistant to PK digestion than the HY product. These data demonstrate that non-mammalian sources of recombinant HaPrP can be converted into PK-resistant form and that strain-mediated properties can be transmitted into the newly formed PrP-res.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-10-2565
2000-10-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/10/0812565a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-10-2565&mimeType=html&fmt=ahah

References

  1. Aucouturier P., Kascsak R. J., Frangione B., Wisniewski T. 1999; Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt–Jakob disease. Neuroscience Letters 274:33–36
    [Google Scholar]
  2. Bartz J. C., Bessen R. A., McKenzie D., Marsh R. F., Aiken J. M. 2000; Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. Journal of Virology 74:5542–5547
    [Google Scholar]
  3. Bessen R. A., Marsh R. F. 1992a; Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. Journal of Virology 66:2096–2101
    [Google Scholar]
  4. Bessen R. A., Marsh R. F. 1992b; Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. Journal of General Virology 73:329–334
    [Google Scholar]
  5. Bessen R. A., Marsh R. F. 1994; Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. Journal of Virology 68:7859–7868
    [Google Scholar]
  6. Bessen R. A., Kocisko D. A., Raymond G. J., Nandan S., Lansbury P. T., Caughey B. 1995; Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375:698–700
    [Google Scholar]
  7. Bossers A., Belt P. B. G., Raymond G. J., Caughey B., De Vries R., Smits M. A. 1997; Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proceedings of the National Academy of Sciences, USA 94:4931–4936
    [Google Scholar]
  8. Caughey B., Chesebro B. 1997; Prion protein and the transmissible spongiform encephalopathies. Trends in Cell Biology 7:56–62
    [Google Scholar]
  9. Caughey B., Kocisko D. A., Raymond G. J., Lansbury P. T. 1995; Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chemistry & Biology 2:807–817
    [Google Scholar]
  10. Caughey B., Raymond G. J., Kocisko D. A., Lansbury P. T. 1997; Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. Journal of Virology 71:4107–4110
    [Google Scholar]
  11. Caughey B., Raymond G. J., Bessen R. A. 1998; Strain-dependent differences in β-sheet conformations of abnormal prion protein. Journal of Biological Chemistry 273:32230–32235
    [Google Scholar]
  12. Chesebro B., Wehlry K., Caughey B., Nishio J., Ernst D., Race R. 1993; Foreign PrP expression and scrapie infection in tissue culture cell lines. Developments in Biological Standardization 80:131–140
    [Google Scholar]
  13. Cohen F. E., Prusiner S. B. 1998; Pathologic conformations of prion proteins. Annual Review of Biochemistry 67:793–819
    [Google Scholar]
  14. Collinge J., Sidle K. C., Meads J., Ironside J., Hill A. F. 1996; Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690
    [Google Scholar]
  15. DebBurman S. K., Raymond G. J., Caughey B., Lindquist S. 1997; Chaperone-supervised conversion of prion protein to its protease-resistant form. Proceedings of the National Academy of Sciences, USA 94:13938–13943
    [Google Scholar]
  16. Harper J. O., Lansbury P. T. 1997; Models of amyloid seeding in Alzheimer’s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annual Review of Biochemistry 66:385–407
    [Google Scholar]
  17. Hill A. F., Desbruslais M., Joiner S., Sidle K. C. L., Gowland I., Collinge J., Doey L., Lantos P. 1997; The same prion strain causes nvCJD and BSE. Nature 389:448–450
    [Google Scholar]
  18. Hill A. F., Antoniou M., Collinge J. 1999; Protease-resistant prion protein produced in vitro lacks detectable infectivity. Journal of General Virology 80:11–14
    [Google Scholar]
  19. Hornemann S., Korth C., Oesch B., Riek R., Wider G., Wuthrich K., Glockshuber R. 1997; Recombinant full length murine prion protein, mPrP (23–231): purification and spectroscopic characterization. FEBS Letters 413:277–281
    [Google Scholar]
  20. Jarrett J. T., Lansbury P. T. 1993; Seeding ‘‘one dimensional crystallization′ of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie?. Cell 73:1055–1058
    [Google Scholar]
  21. Kascsak R. J., Rubenstein R., Tonna-DeMasi R., Wisniewski H. M., Diringer H. 1987; Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. Journal of Virology 61:3688–3693
    [Google Scholar]
  22. Kocisko D. A., Come J. H., Priola S. A., Chesebro B., Raymond G. J., Lansbury P. T. Jr, Caughey B. 1994; Cell-free formation of protease-resistant prion protein. Nature 370:471–474
    [Google Scholar]
  23. Kocisko D. A., Priola S. A., Raymond G. J., Chesebro B., Lansbury P. T., Caughey B. 1995; Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proceedings of the National Academy of Sciences, USA 92:3923–3927
    [Google Scholar]
  24. Kocisko D. A., Lansbury P. T., Caughey B. 1996; Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry 35:13434–13442
    [Google Scholar]
  25. Kuczius T., Groschup M. H. 1999; Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Molecular Medicine 5:406–418
    [Google Scholar]
  26. McKenzie D., Bartz J., Marsh R. F. 1996; Transmissible mink encephalopathy. Seminars in Virology 7:201–206
    [Google Scholar]
  27. McKenzie D., Bartz J., Mirwald J., Olander D., Marsh R., Aiken J. 1998; Reversibility of scrapie inactivation is enhanced by copper. Journal of Biological Chemistry 273:25545–25547
    [Google Scholar]
  28. McKenzie D., Bartz J., Mirwald J., Iniguez V., Aiken J. 1999; Copper and zinc enhance the renaturation of PrPSc and restore infectivity. In New Aspects of Trace Element Research pp 241–244 Edited by Abdulla M., Bost M., Gamon S., Arnaud P., Chazot G. London: Smith Gordon;
    [Google Scholar]
  29. Mehlhorn I., Groth D., Stockel J., Moffat B., Reilly D., Yansura D., Willet W. S., Baldwin M., Fletterick R., Cohen F. E., Vandlen R., Henner D., Prusiner S. B. 1996; High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35:5528–5537
    [Google Scholar]
  30. Negro A., De Filippis V., Skaper S. D., James P., Sorgato M. C. 1997; The complete mature bovine prion protein highly expressed in Escherichia coli : biochemical and structural studies. FEBS Letters 412:359–364
    [Google Scholar]
  31. Oesch B., Westaway D., Wälchli M., McKinley M. P., Kent S. B. H., Aebersold R., Barry R. A., Tempst P., Teplow D. B., Hood L. E., Prusiner S. B., Weissmann C. 1985; A cellular gene encodes scrapie PrP 27–30 protein. Cell 40:735–746
    [Google Scholar]
  32. Parchi P., Castellani S., Capellari S., Ghetti B., Young K., Chen S. G., Farlow M., Dickson D. W., Sima A. A., Trojanowski J. Q., Petersen R. B., Gambetti P. 1996; Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Annals of Neurology 39:767–778
    [Google Scholar]
  33. Pergami P., Jaffe H., Safar J. 1996; Semipreparative chromatographic method to purify the normal cellular isoform of the prion protein in nondenatured form. Annals of Biochemistry 236:63–73
    [Google Scholar]
  34. Priola S. A., Caughey B., Wehrly K., Chesebro B. 1995; A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. Journal of Biological Chemistry 270:3299–3305
    [Google Scholar]
  35. Prusiner S. B. 1991; Molecular biology of prion diseases. Science 252:1515–1522
    [Google Scholar]
  36. Prusiner S. B. 1998; Prions. Proceedings of the National Academy of Sciences, USA 95:13363–13383
    [Google Scholar]
  37. Raymond G. J., Hope J., Kocisko D. A., Priola S. A., Raymond L. D., Bossers A., Ironside J., Will R. G., Cheng S. G., Petersen R. B., Gambetti P., Rubenstein R., Smits M. A., Lansbury P. T., Caughey B. 1997; Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388:285–288
    [Google Scholar]
  38. Rubenstein R., Gray P. C., Wehlburg C. M., Wagner J. S., Tisone G. C. 1998; Detection and discrimination of PrPSc by multi-spectral ultraviolet fluorescence. Biochemical and Biophysical Research Communications 246:100–106
    [Google Scholar]
  39. Saborio G. P., Soto C., Kascsak R. J., Levy E., Kascsak R., Harris D. A., Frangione B. 1999; Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochemical and Biophysical Research Communications 250:187–193
    [Google Scholar]
  40. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F. E., Prusiner S. B. 1998; Eight prion strains have PrPSc molecules with different conformations. Nature Medicine 10:1157–1165
    [Google Scholar]
  41. Scott M. R., Buttler D. A., Bredesen D. E., Wälchli M., Hsiao K. K., Prusiner S. B. 1988; Prion protein gene expression in cultured cells. Protein Engineering 2:69–76
    [Google Scholar]
  42. Telling G. C., Parchi P., DeArmond S. J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S. B. 1996; Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082
    [Google Scholar]
  43. Turk E., Teplow D. B., Hood L. E., Prusiner S. B. 1988; Purification and properties of the cellular and scrapie hamster prion proteins. European Journal of Biochemistry 176:21–31
    [Google Scholar]
  44. Weiss S., Famulok M., Edenhofer F., Wang Y. H., Jones I. M., Groshup M., Winnacker E. L. 1995; Overexpression of active Syrian golden hamster prion protein PrPC as a glutathione S-transferase fusion in heterologous systems. Journal of Virology 69:4776–4783
    [Google Scholar]
  45. Westaway D., Telling G. C., Priola S. 1998; Prions. Proceedings of the National Academy of Sciences, USA 95:11030–11031
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-10-2565
Loading
/content/journal/jgv/10.1099/0022-1317-81-10-2565
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error